A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection

被引：0
|
作者：
姚光弼
王宝恩
崔振宇
姚集鲁
曾民德
机构：
来源：
中华医学杂志(英文版) | 1999年 / 05期
关键词：
lamivudine · hepatitis B virus · chronic hepatitis B;
D O I：
暂无
中图分类号：
R512.62 [];
学科分类号：
100401 ;
摘要：
ＯｂｊｅｃｔｉｖｅＴｏｅｖａｌｕａｔｅｔｈｅｅｆｅｃｔｏｆｌａｍｉｖｕｄｉｎｅｏｎｔｈｅｌｏｓｓｏｆｓｅｒｕｍｈｅｐａｔｉｔｉｓＢｖｉｒｕｓ（ＨＢＶ）ＤＮＡ，ＨＢｅＡｇ／ａｎｔｉＨＢｅｓｅｒｏｃｏｎｖｅｒｓｉｏｎａｎｄＡＬＴｌｅｖｅｌｓｉｎｃｈｒｏｎ...
引用
收藏
页码：3 / 7
页数：2
相关论文
共 50 条
  • [1] A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection
    姚光弼
    王宝恩
    崔振宇
    姚集鲁
    曾民德
    [J]. ChineseMedicalJournal, 1999, (05)
  • [2] A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection
    Yao, GB
    Wang, BE
    Cui, ZY
    Yao, JL
    Zeng, MD
    [J]. CHINESE MEDICAL JOURNAL, 1999, 112 (05) : 387 - 391
  • [3] Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study
    Xu, W. -M.
    Cui, Y. -T.
    Wang, L.
    Yang, H.
    Liang, Z. -Q.
    Li, X. -M.
    Zhang, S. -L.
    Qiao, F. -Y.
    Campbell, F.
    Chang, C. -N.
    Gardner, S.
    Atkins, M.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2009, 16 (02) : 94 - 103
  • [4] A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B
    Lim, SG
    Ng, TM
    Kung, N
    Krastev, Z
    Volfova, M
    Husa, P
    Lee, SS
    Chan, S
    Shiffman, ML
    Washington, MK
    Rigney, A
    Anderson, J
    Mondou, E
    Snow, A
    Sorbel, J
    Guan, R
    Rousseau, F
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (01) : 49 - 56
  • [5] Long-term efficacy of lamivudine in the treatment of patients with chronic hepatitis B virus infection - A multicenter randomised, double-blind, placebo controlled trial
    Yao, G
    Wang, B
    Cui, Z
    Yao, J
    Minde, Z
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A848 - A848
  • [6] An international double-blind placebo-controlled trial of lamivudine in 286 children with chronic hepatitis B (CHB)
    Sokal, EM
    Kelly, D
    Mizerski, J
    Badia, I
    Areias, J
    Schwarz, K
    Little, N
    Bell, S
    Greensmith, MJ
    Jonas, M
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 23 - 23
  • [7] A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection
    Main, J
    Brown, JL
    Howells, C
    Galassini, R
    Crossey, M
    Karayiannis, P
    Georgiou, P
    Atkinson, G
    Thomas, HC
    [J]. JOURNAL OF VIRAL HEPATITIS, 1996, 3 (04) : 211 - 215
  • [8] Thymosin α1 treatment of chronic hepatitis B:: results of a phase III multicentre, randomized, double-blind and placebo-controlled study
    Mutchnick, MG
    Lindsay, KL
    Schiff, ER
    Cummings, GD
    Appelman, HD
    Peleman, RR
    Silva, M
    Roach, KC
    Simmons, F
    Milstein, S
    Gordon, SC
    Ehrinpreis, MN
    [J]. JOURNAL OF VIRAL HEPATITIS, 1999, 6 (05) : 397 - 403
  • [9] Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study
    Zein, NN
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (03) : 315 - 322
  • [10] Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial
    Chan, Henry Lik-Yuen
    Wang, Hao
    Niu, Junqi
    Chim, Angel Mei-Ling
    Sung, Joseph Jao-Yiu
    [J]. ANTIVIRAL THERAPY, 2007, 12 (03) : 345 - 353
12345